In Vivo Renal Lipid Quantification by Accelerated Magnetic Resonance Spectroscopic Imaging at 3T: Feasibility and Reliability Study

dc.contributor.authorAlhulail, Ahmad A.
dc.contributor.authorServati, Mahsa
dc.contributor.authorOoms, Nathan
dc.contributor.authorAkin, Oguz
dc.contributor.authorDincer, Alp
dc.contributor.authorThomas, M. Albert
dc.contributor.authorDydak, Ulrike
dc.contributor.authorEmir, Uzay E.
dc.contributor.departmentRadiology and Imaging Sciences, School of Medicineen_US
dc.date.accessioned2023-06-16T16:38:14Z
dc.date.available2023-06-16T16:38:14Z
dc.date.issued2022-04-23
dc.description.abstractA reliable and practical renal-lipid quantification and imaging method is needed. Here, the feasibility of an accelerated MRSI method to map renal fat fractions (FF) at 3T and its repeatability were investigated. A 2D density-weighted concentric-ring-trajectory MRSI was used for accelerating the acquisition of 48 × 48 voxels (each of 0.25 mL spatial resolution) without respiratory navigation implementations. The data were collected over 512 complex-FID timepoints with a 1250 Hz spectral bandwidth. The MRSI sequence was designed with a metabolite-cycling technique for lipid-water separation. The in vivo repeatability performance of the sequence was assessed by conducting a test-reposition-retest study within healthy subjects. The coefficient of variation (CV) in the estimated FF from the test-retest measurements showed a high degree of repeatability of MRSI-FF (CV = 4.3 ± 2.5%). Additionally, the matching level of the spectral signature within the same anatomical region was also investigated, and their intrasubject repeatability was also high, with a small standard deviation (8.1 ± 6.4%). The MRSI acquisition duration was ~3 min only. The proposed MRSI technique can be a reliable technique to quantify and map renal metabolites within a clinically acceptable scan time at 3T that supports the future application of this technique for the non-invasive characterization of heterogeneous renal diseases and tumors.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationAlhulail AA, Servati M, Ooms N, et al. In Vivo Renal Lipid Quantification by Accelerated Magnetic Resonance Spectroscopic Imaging at 3T: Feasibility and Reliability Study. Metabolites. 2022;12(5):386. Published 2022 Apr 23. doi:10.3390/metabo12050386en_US
dc.identifier.urihttps://hdl.handle.net/1805/33820
dc.language.isoen_USen_US
dc.publisherMDPIen_US
dc.relation.isversionof10.3390/metabo12050386en_US
dc.relation.journalMetabolitesen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0*
dc.sourcePMCen_US
dc.subjectKidneyen_US
dc.subjectRenalen_US
dc.subjectLipiden_US
dc.subjectFast MRSIen_US
dc.titleIn Vivo Renal Lipid Quantification by Accelerated Magnetic Resonance Spectroscopic Imaging at 3T: Feasibility and Reliability Studyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
metabolites-12-00386.pdf
Size:
1.38 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: